Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Ophthalmol ; 89(8): e635-44, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21801333

RESUMO

PURPOSE: The identification of cells with properties of retinal progenitor cells (RPCs) in the adult human ciliary margin (CM) prompted a number of studies of their proliferative and differentiation potential. One of the remaining challenges is to find a feasible method of isolating RPCs from the patient's eye. In the human CM, only the iris pigment epithelium (IPE) is easily obtained by a minimally invasive procedure. In the light of recent studies questioning the existence of RPCs in the adult mammalian CM, we wanted to assess the potential of the adult human IPE as source of RPCs. METHODS: The IPE were isolated from peripheral iridectomies during glaucoma surgery, and IPE and ciliary body (CB) epithelium were also isolated from post-mortem tissue. Cells were cultivated in sphere-promoting conditions or as monolayers. Whole-tissue samples, undifferentiated and differentiated cells were studied by immunocytochemistry, RT-PCR and transmission electron microscopy. RESULTS: The adult human IPE, like the CB, expressed markers of RPCs such as Pax6, Sox2 and Nestin in vivo. Both sphere-promoting and monolayer cultures preserved this phenotype. However, both IPE/CB cultures expressed markers of differentiated epithelial cells such as Claudin, microphtalmia-associated transcription factor (MITF) and Cytokeratin-19. Ultrastructurally, IPE spheres displayed epithelial-like junctions and contained mature melanosomes. After induced differentiation, IPE-derived cells showed only partial neuronal differentiation expressing ß-III-tubulin, Map-2 and Rhodopsin, whereas no mature glial markers were found. CONCLUSION: Proliferative cells with some properties of RPCs can be isolated from the adult human IPE by peripheral iridectomies. Yet, many cells retain properties of differentiated epithelial cells and lack central properties of somatic stem cells.


Assuntos
Iridectomia , Iris/citologia , Epitélio Pigmentado Ocular/citologia , Epitélio Pigmentado da Retina/citologia , Células-Tronco/ultraestrutura , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/metabolismo , Proliferação de Células , Separação Celular , Células Cultivadas , Corpo Ciliar/citologia , Corpo Ciliar/metabolismo , Primers do DNA/química , Técnica Indireta de Fluorescência para Anticorpo , Glaucoma/cirurgia , Humanos , Iris/metabolismo , Microscopia Eletrônica de Transmissão , Pessoa de Meia-Idade , Epitélio Pigmentado Ocular/metabolismo , Epitélio Pigmentado da Retina/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células-Tronco/metabolismo
2.
Biochem Biophys Res Commun ; 410(3): 682-7, 2011 Jul 08.
Artigo em Inglês | MEDLINE | ID: mdl-21699885

RESUMO

We have previously reported the in vitro anti-proliferative effect of 4-thio-uridylate (s(4)UMP) on OCM-1 uveal melanoma cells. Here, we assessed the efficacy of s(4)UMP on JY cells. Treatment of JY cells with s(4)UMP suppressed their colony forming activity and induced apoptosis; healthy human bone marrow granulocyte-macrophage progenitor cells were 14-fold less sensitive to the nucleotide. In vivo effectiveness of s(4)UMP was determined using xenograft SCID mouse model. s(4)UMP decreased the cell number and colony forming activity of the total cell content of the femur of SCID mice transplanted with JY cells without affecting the bone marrow of healthy mice. These results suggest that s(4)UMP alone or in combination with other clinically approved anti-leukemic remedies should be further explored as a potential novel therapeutic agent.


Assuntos
Antineoplásicos/uso terapêutico , Leucemia de Células B/tratamento farmacológico , Tionucleotídeos/uso terapêutico , Uridina Monofosfato/análogos & derivados , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Humanos , Camundongos , Camundongos SCID , Células-Tronco/efeitos dos fármacos , Tionucleotídeos/química , Tionucleotídeos/farmacocinética , Uridina Monofosfato/química , Uridina Monofosfato/farmacocinética , Uridina Monofosfato/uso terapêutico , Ensaios Antitumorais Modelo de Xenoenxerto
3.
Acta Ophthalmol ; 89(1): e30-4, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21091941

RESUMO

PURPOSE: Failure of retinal pigment epithelial (RPE) cells and macrophages to engulf different dying cells in the retina may result in accumulation of debris and development of age-related macular degeneration (AMD). The dynamics and influence of different treatments on this clearance process can be studied in vitro using human ARPE-19 cells and macrophages as phagocytes modelling dry and wet type of AMD, respectively. METHODS: Death through extracellular matrix detachment using polyHEMA-coated surfaces (anoikis) and UV irradiation (apoptosis) was induced in ARPE-19 cells. Two-coloured phagocytic assays were performed to quantify the amount of dying cells phagocytes engulfed (flow cytometry) and for visualization (fluorescent and scanning electron microscopy). The effect of phosphatidylserine inhibition with recombinant annexin-V and glucocorticoid (triamcinolone) treatment on the phagocytic process was tested. RESULTS: The clearance of anoikic and apoptotic cells by nondying ARPE-19 cells over 8 hr of co-incubation increased over time (at 8 hr, over 53% and 35% of the phagocytes contained engulfed dying cells, respectively). The human macrophages engulfed the anoikic and apoptotic ARPE-19 cells with seven and four times lower capacity, respectively. Phosphatidylserine appearance on the dying cells did not affect, but triamcinolone treatment enhanced the phagocytosis of the dying cells by macrophages. CONCLUSIONS: ARPE-19 cells are more efficient in clearing anoikic than UV-induced apoptotic cells. Macrophages are less efficient in the clearance process than ARPE-19 cells. The present model can be used for studying both dry and wet type of AMD in vitro and for testing different pharmacological aspects affecting this disease.


Assuntos
Macrófagos/fisiologia , Degeneração Macular/metabolismo , Fagocitose/fisiologia , Epitélio Pigmentado da Retina/citologia , Anexina A5/farmacologia , Anoikis/efeitos dos fármacos , Anoikis/efeitos da radiação , Sobrevivência Celular/fisiologia , Células Cultivadas , Relação Dose-Resposta à Radiação , Citometria de Fluxo , Humanos , Microscopia Eletrônica de Varredura , Microscopia de Fluorescência , Modelos Biológicos , Fagocitose/efeitos dos fármacos , Fosfatidilserinas/antagonistas & inibidores , Fosfatidilserinas/metabolismo , Epitélio Pigmentado da Retina/metabolismo , Fatores de Tempo , Triancinolona/farmacologia
4.
Pharmacol Rep ; 61(2): 343-7, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19443949

RESUMO

In this short communication, it is shown that 4-thio-uridylate (s(4)UMP, designated as UD29) inhibits glyceraldehyde 3-phosphate dehydrogenase (GAPDH), suggesting that the enol-form of the thiolated nucleotide may interfere with the function of the essential -SH group in the active center of the enzyme. Since HIV entry requires thiol/disulfide exchange processes, this activity prompted us to study the anti-HIV activity of the nucleotide. Indeed, UD29 inhibited the replication of HIV-1(IIIB) in the MT-4 cell line and HIV-1(Ada-M) in peripheral blood mononuclear cells (PBMC). Furthermore, UD29 was not toxic in PBMCs in vitro or in mice when the compound was administered intravenously.


Assuntos
Fármacos Anti-HIV/farmacologia , Inibidores Enzimáticos/farmacologia , Gliceraldeído-3-Fosfato Desidrogenases/antagonistas & inibidores , HIV-1/efeitos dos fármacos , Compostos de Sulfidrila/metabolismo , Tionucleotídeos/farmacologia , Uridina Monofosfato/análogos & derivados , Replicação Viral/efeitos dos fármacos , Animais , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Uridina Monofosfato/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...